Why?
May 6
FDA advisory panel to review Questcor Pharmaceuticals'(QCOR) Acthar for
infantile spasms. The FDA's briefing documents should be posted to the
agency's web site on May 4 or May 5.
K********g 发帖数: 9389
2
我本不看好，但是今天过了么？
【在 p********e 的大作中提到】 : Why? : May 6 : FDA advisory panel to review Questcor Pharmaceuticals'(QCOR) Acthar for : infantile spasms. The FDA's briefing documents should be posted to the : agency's web site on May 4 or May 5.
